Clinicopath Conf
Spongiform Encephalopathy (Creutzfeldt-Jakob Disease) , with Amyloid (KURU) Plaques, Case 17-1993, N, JM 328:66,1993., 1993
Efficacy of Ticlopidine & Aspirin for Prev of Rev Cerebrovascular Ischemic Events, Ticlopidine Aspirin Study
Stroke 24:1452-1457, Bellavance,A.,et al, 1993
Current Management of Ischaemic Stroke
JNNP 56:6-16, Marshall,R.S.&Mohr,J.P., 1993
Cranial Neuropathy Heralding Otherwise Occult AIDS-Related Large Cell Lymphoma
J Clin Neuro-Ophthalmol 13:113-118, Berger,J.R.,et al, 1993
Brain Imaging in Late-Onset CM2 Gangliosidosis
Neurol 43:2055-2058, Streifler,J.Y.,et al, 1993
Secondary Prevention in Non-Rheumatic Atrial Fib After TIA or Minor Stroke
European Atrial Fibrillation Trial Study Group, Lancet 342:1255-1262, 1251-1252993., , 1993
Smoking Cessation and Decreased Risk of Stroke in Women
JAMA 269:232-236, Kawachi,I.,et al, 1993
Risk of Stroke in Adults With Cyanotic Congenital Heart Disease
Circulation 87:1954-1959, Perloff,J.K. et al, 1993
Stroke Complic Acute MI, A Meta-Analysis of Risk Modific by Antigoac & Thrombolytic Therapy
Arch Int Med 152:2020-2024, Viatkus,P.T.,et al, 1992
Role of Prophyl Anticoag for Direct Current Cardiover in Pts with Atrial Fib, Atrial Flutter
J Am Coll Cardiol 19:851-855, Zeiler,A.,et al, 1992
Clinicopath Conf
PEOMS Syndrome, Case 39-1992, NEJM 327:1014-1021992., , 1992
Ticlopidine vs Aspirin for Prevention of Recurrent Stroke, Analysis of Pts with Stroke from Ticlopidine Aspirin Study
Stroke 23:1723-1727, Harbison,J.W., 1992
Effects of Low-to-High Doses of Aspirin on Platelet Aggregab & Metabol of Thromboxane A2 & Prostacyclin
Stroke 23:1400-1403, Tohgi,H.,et al, 1992
Low-Dose Aspirin and Stroke"It Ain't Necessarily So"
Stroke 23:1395-1399, Dyken,M.L.,et al, 1992
Prevention of Stroke with Ticlopidine:Who Benefits Most?
Neurol 42:111-115, Grotta,J.C.,et al, 1992
Predictors of Thromboembolism in Atrial Fibrillation:I. Clinical Features of patients at Risk
The Stroke Prevention in A Fib Investigators, Ann Int Med 116:1-51992., , 1992
Physical Activity and Stroke in British Middle Aged Men
BMJ 304:597-601, Wannamethee,G.&Shaper,A.G., 1992
Chronic Neurodegenerative Disease Associated with HTLV-II Infection
Lancet 339:645-646, Hjelle,B.,et al, 1992
Paraneoplastic Syndrome Manifesting as Chronic Cerebellar Ataxia in a Child with Hodgkin Disease
J Pediatr 120:275-277, Topeu,M.,et al, 1992
Primary Prevention of Stroke
Lancet 339:344-347, Marmot,M.C.&Poultier,N.R., 1992
Secondary Prevention of Stroke
Lancet 339:724-727, Warlow,C., 1992
Crossed Cerebellar Diaschisis and Crossed Cerebellar Atrophy:MR Findings & Clin Symptoms in 26 Pts
AJR 158:1155-1159, Tien,R.D.&Ashdown,B.C., 1992
Role of Ticlopidine for Prevention of Stroke
Stroke 23:912-916, Albers,G.W., 1992
European Stroke Prevention Study:Effectiveness of Antiplatelet Therapy in Diabetics in Secondary Prevent of Stroke
Stroke 23:851-854, Sivenius,J.,et al, 1992
Trends in Mortality, Morbidity, and Risk Factor Levels for Stroke from 1960 through 1990
JAMA 268:753-759, McGovern,P.G.,et al, 1992
Hypertension and the Brain
Arch Int Med 152:938-945, Phillips,S.J.,et al, 1992
Amount of Smoking Independently Predicts Carotid Artery Atherosclerosis Severity
Stroke 23:693-696, Dempsey,R.J.&Moore,R.W., 1992
Preventable Senility:A Call for Action Against the Vascular Dementias
Lancet 340:645-648, Hachinski,V., 1992
Ticlopidine for Prevention of Stroke
The Medical Letter, 34:65-661992., , 1992
A Critical Appraisal of Ticlopidine, A New Antiplat Agent, Effectiveness & Clin Indic for Prophylaxis
Arch Int Med 152:1376-1380, Haynes,R.B.,et al, 1992
Spontaneous Remission of a Third-Nerve Palsy in Meningeal Lymphoma
Ann Neurol 32:100-102, Galetta,S.L.,et al, 1992
The Use of Transcranial Ultrasonography to Predict Stroke in Sickle Cell Disease
NEJM 326:605-610, 6371992., Adams,R.,et al, 1992
Paraneoplastic Cerebellar Degener III, Cerebellar Degener, Cancer & Lambert-Eaton Myasthenic Synd
Neurol 42:1944-1950, Clouston,P.D.,et al, 1992
Paraneoplastic Cerebellar Degener II, Clin & Immunologic Find in 21 Pts with Hodgkin's Disease
Neurol 42:1938-1943, Hammack,J.,et al, 1992
Paraneoplastic Cerebellar Degener I A Clinical Analysis of 55 Anti-Yo Antibody-Positive Pts
Neurol 42:1931-1937, Peterson,K.,et al, 1992
The Use of Magnetic Resonance Imaging in Diagnosing Infantile Neuroaxonal Dystrophy
Neurol 43:110-113, Tanabe,Y.,et al, 1992
Cost Effectiveness of Primary Stroke Prevention in Atrial Fibrillation
BMJ 305:1457-1460, 14451992., Gustafsson,C.,et al, 1992
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
NEJM 327:1406-1412, 14511992., Ezekowitz,M.D.,et al, 1992
Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991
Stroke Prevention in Nonvalvular Atrial Fibrillation:A Review of Prospective Randomized Trials
Ann Neurol 30:511-518, Albers,G.W.,et al, 1991
Influence of Low-Intensity Warfarin Treatment of Patients'Perceptions of Quality of Life
Editorial, Arch Int Med 151:1921-1922, 1944-1949991., , 1991
Stroke Prevention in Nonvalvular Atrial Fibrillation
Ann Int Med 115:727-736, Albers,G.W.,et al, 1991
Physicians'Attitudes Toward Anticoag & Antiplat Agents for Stroke Prevent in Elderly Pts with Atrial Fib
Arch Int Med 151:1950-1953, 19221991., Kutner,M.,et al, 1991
Chronic Blood Hyperviscosity in Subjects with Acute Stroke, Transient Ischemic Attack, & Risk Factors for Stroke
Stroke 22:162-168, Coull,B.M.,et al, 1991
The Canadian Coop Trial of Cyclophosphamide and Plasma Exchange in Progr MS
The Canadian Coop MS Study Group, Lancet 337:441-4461991., , 1991
Ticlopidine
Editorial, Lancet 337:459-4601991., , 1991
CT Appearance of Primary CNS Lymphoma in Patients with Acquired Immunodeficiency Syndrome
J Comput Assist Tomogr 15:39-44, Goldstein,J.D.,et al, 1991
Primary Leptomeningeal Lymphoma:Report of 9 Cases, Dx with Immunocytochemical Analysis & Review
Neurol 41:95-100, Lachance,D.H.,et al, 1991
Intense Immunosuppression in Chronic Progressive Multiple Sclerosis:The Kaiser Study
JNNP 54:1055-1060, Likosky,W.H.,et al, 1991
A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg/day) in Pats. After a TIA or Minor Ischemic Stroke
Dutch TIA Trial Study Group, NEJM 325:1261-1266, 1303991., , 1991